RxNorm Semantic Concepts Index - 342
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "342".
Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
Concept ID (RxCUI): 34213 | Polyphosphate kinase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 34213 | Polyphosphate kinase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 34214 | Polyphosphate-glucose phosphotransferase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 34214 | Polyphosphate-glucose phosphotransferase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 342280 | Inspra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
Concept ID (RxCUI): 342285 | Hepsera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
Concept ID (RxCUI): 3423 | Dihydromorphinone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 3423 | Dihydromorphinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
Concept ID (RxCUI): 3423 | Dihydromorphinone | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 3423 | Dihydromorphinone | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
Concept ID (RxCUI): 3423 | Dihydromorphinone | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 3423 | Dihydromorphinone | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 3423 | Dihydromorphinone | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 342369 | lenalidomide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
Concept ID (RxCUI): 342369 | lenalidomide | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 342369 | lenalidomide | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 342369 | lenalidomide | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 342369 | lenalidomide | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 3424 | 20-alpha hydroxyprogesterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 3424 | 20-alpha hydroxyprogesterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 3424 | 20-alpha hydroxyprogesterone | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 3424 | 20-alpha hydroxyprogesterone | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 34246 | polymyxin B / trimethoprim Ophthalmic Solution [Polytrim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
Concept ID (RxCUI): 3425 | Dihydropteridine reductase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 3425 | Dihydropteridine reductase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 3426 | Dihydropteroate pyrophosphorylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 3426 | Dihydropteroate pyrophosphorylase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 3426 | Dihydropteroate pyrophosphorylase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 342691 | treprostinil sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
Concept ID (RxCUI): 342691 | treprostinil sodium | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 342691 | treprostinil sodium | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 342786 | sodium lactate 19 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342788 | xenon 0.05 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342799 | nadroparin 25000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342800 | mold extract 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342801 | mold extract 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342802 | poison ivy extract 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342803 | cefuroxime 95 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342840 | sennosides, USP 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342853 | glucose 72.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342854 | glucose 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342855 | glucose 82.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342856 | cetalkonium chloride 0.181 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342858 | poloxamer 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342864 | diphtheria toxoid vaccine, inactivated 0.2 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342866 | ethanol 3.87 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342867 | ethanol 6.5 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342868 | ethanol 2 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342869 | benzalkonium 0.0015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342870 | ethanol 3.5 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342871 | benzyl alcohol 0.6 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342872 | nadroparin 9500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342873 | isopropyl alcohol 8.7 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342874 | methicillin sodium 90 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342875 | methicillin sodium 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342877 | benzyl alcohol 0.09 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342879 | Trichophyton (fungus) 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342881 | cefamandole 285 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342882 | benzyl alcohol 0.05 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342885 | capreomycin 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342886 | cefoperazone 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342888 | gonadorelin 0.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342890 | cilastatin 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342891 | imipenem 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342892 | mezlocillin 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342893 | vancomycin 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342894 | trimetrexate 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342896 | ceFAZolin 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342896 | ceFAZolin 200 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
Concept ID (RxCUI): 342898 | didanosine 0.847 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 3429 | Dihydrotachysterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
Concept ID (RxCUI): 3429 | Dihydrotachysterol | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 3429 | Dihydrotachysterol | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 3429 | Dihydrotachysterol | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 3429 | Dihydrotachysterol | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 34290 | Cystatin C | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 34290 | Cystatin C | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 342901 | thiopental 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342902 | urea 600 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342903 | nicotine 0.875 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342915 | cytomegalovirus immune globulin 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342916 | acetaminophen 1.06 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342917 | aspirin 2.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342918 | caffeine 0.137 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342926 | octreotide 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342927 | octreotide 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342928 | octreotide 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342929 | cefmetazole 370 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342930 | cefmetazole 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342931 | ampicillin 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342932 | sulbactam 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342933 | somatropin 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342935 | ceftizoxime 270 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342936 | ceftizoxime 280 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342937 | ceftizoxime 286 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342938 | isopropyl alcohol 9.8 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342940 | pau d'arco preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
Concept ID (RxCUI): 342941 | 4-aminobenzoic acid 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342947 | topotecan 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342949 | vindesine 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342950 | somatropin 12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 342952 | sermorelin 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342953 | sermorelin 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342955 | ticarcillin 385 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342956 | ticarcillin 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342957 | ceftizoxime (as ceftizoxime sodium) 280 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 342957 | ceftizoxime (as ceftizoxime sodium) 280 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 342957 | ceftizoxime (as ceftizoxime sodium) 280 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 342957 | ceftizoxime (as ceftizoxime sodium) 280 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 342958 | ceftizoxime (as ceftizoxime sodium) 20 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 342958 | ceftizoxime (as ceftizoxime sodium) 20 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 342958 | ceftizoxime (as ceftizoxime sodium) 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 342958 | ceftizoxime (as ceftizoxime sodium) 20 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 342959 | ceftizoxime 40 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 34296 | potassium bicarbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
Concept ID (RxCUI): 34296 | potassium bicarbonate | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 34296 | potassium bicarbonate | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 34296 | potassium bicarbonate | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 34296 | potassium bicarbonate | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 342960 | ticarcillin (as ticarcillin disodium) 100 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 342960 | ticarcillin (as ticarcillin disodium) 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
Concept ID (RxCUI): 342960 | ticarcillin (as ticarcillin disodium) 100 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 342960 | ticarcillin (as ticarcillin disodium) 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 342964 | cetalkonium chloride 0.182 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342965 | Sodium cellulose phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 342965 | Sodium cellulose phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
Concept ID (RxCUI): 342965 | Sodium cellulose phosphate | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 342965 | Sodium cellulose phosphate | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 342965 | Sodium cellulose phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
Concept ID (RxCUI): 342967 | glucose 5556 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342973 | simethicone 200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
Concept ID (RxCUI): 342974 | glutamine 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
Concept ID (RxCUI): 342977 | etanercept 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
Concept ID (RxCUI): 34298 | potassium bromate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
Concept ID (RxCUI): 342986 | (R)-Aminopropanol dehydrogenase | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 342986 | (R)-Aminopropanol dehydrogenase | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 34299 | potassium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
Concept ID (RxCUI): 34299 | potassium bromide | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 34299 | potassium bromide | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 34299 | potassium bromide | Designated preferred name (PT) | YES | |
Concept ID (RxCUI): 34299 | potassium bromide | Full form of descriptor (FN) | YES | |
Concept ID (RxCUI): 342992 | Piperazine citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
Concept ID (RxCUI): 342992 | Piperazine citrate | Designated preferred name (PT) | NO | |
Concept ID (RxCUI): 342992 | Piperazine citrate | Full form of descriptor (FN) | NO | |
Concept ID (RxCUI): 342998 | Norplant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |